These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An analysis of the reported association of oral contraceptives to thromboembolic disease. Odell WD. West J Med; 1975 Jan; 122(1):26-33. PubMed ID: 1089003 [No Abstract] [Full Text] [Related]
13. Serious adverse effects of oral contraceptives and estrogens. Med Lett Drugs Ther; 1976 Feb 27; 18(5):21-2. PubMed ID: 1256357 [No Abstract] [Full Text] [Related]
14. Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee. Br Med J; 1967 May 06; 2(5548):355-9. PubMed ID: 6023133 [No Abstract] [Full Text] [Related]
15. Investigation of relation between use of oral contraceptives and thromboembolic disease. Vessey MP, Doll R. Br Med J; 1968 Apr 27; 2(5599):199-205. PubMed ID: 5653025 [No Abstract] [Full Text] [Related]
16. Estrogens and thromboembolic diseases. Present conception of a controversial issue. Zador G. Acta Obstet Gynecol Scand Suppl; 1976 Apr 27; 54():13-28. PubMed ID: 788441 [No Abstract] [Full Text] [Related]